Paglalarawan

Outsourcing is an important means for clinical trial sponsors to bring in outside expertise, from full-service clinical research organisations to smaller functional service providers. The global clinical trial outsourcing market is poised to grow by US$ 17.0 bilyon mula sa 2022 sa 2028, pagrehistro ng isang CAGR ng 6.1% sa panahon ng pagtataya, ayon sa StrategyHelix.

Ang ulat ay nagbibigay ng napapanahong data ng laki ng merkado para sa panahon 2018-2021 at forecast na 2028 covering key market aspects like sales value for clinical trial outsourcing. The global clinical trial outsourcing market is segmented on the basis of phase, application, organization size, at rehiyon. By phase, the global clinical trial outsourcing market has been segmented into phase I, phase III, phase III, phase IV. Ayon sa pananaliksik, the phase III segment had the largest share in the global clinical trial outsourcing market. Based upon application, the global clinical trial outsourcing market is categorized into cardiovascular diseases (CVDs), gastrointestinal diseases, infectious diseases, musculoskeletal disorders (MSD), neurological disorders, oncology, iba pa ang iba. Sa 2021, the oncology segment made up the largest share of revenue generated by the clinical trial outsourcing market. On the basis of organization size, the global clinical trial outsourcing market has been segmented into large enterprises, small and medium-sized enterprises (SMEs). Sa mga tuntunin ng heograpiya, the global clinical trial outsourcing market has been segmented into North America, Asya Pasipiko, Europa, Pahinga ng Mundo (ROW).

The global clinical trial outsourcing market is highly competitive. The key players in the clinical trial outsourcing market include Charles River Laboratories International Inc., ICON plc, IQVIA Holdings Inc., Labcorp Drug Development Inc., Medelis Inc., Parexel International Corporation, Syneos Health Inc., Thermo Fisher Scientific Inc., WuXi AppTec Co. Ltd.

Ang ulat ay isang napakahalagang mapagkukunan para sa mga kumpanya at organisasyon na aktibo sa industriyang ito. It provides a cohesive picture of the clinical trial outsourcing market to help drive informed decision making for industry executives, mga gumagawa ng patakaran, akademiko, at mga analyst.

Saklaw ng Ulat

Phase: phase I, phase III, phase III, phase IV
Paglalapat: cardiovascular diseases (CVDs), gastrointestinal diseases, infectious diseases, musculoskeletal disorders (MSD), neurological disorders, oncology, iba pa ang iba
Organization size: large enterprises, small and medium-sized enterprises (SMEs)
Rehiyon: Hilagang Amerika, Asya Pasipiko, Europa, Pahinga ng Mundo (ROW)
Taon na itinuturing: Ang ulat na ito ay sumasaklaw sa panahon 2018 sa 2028

Mga Pangunahing Benepisyo para sa mga Stakeholder

– Get a comprehensive picture of the global clinical trial outsourcing market
– Pinpoint ang mga sektor ng paglago at mga trend para sa pamumuhunan

Talaan ng mga Nilalaman

Bahagi 1. Panimula
– Saklaw ng pag aaral
– Panahon ng pag aaral
– Saklaw ng heograpiya
– Paraan ng pananaliksik
Bahagi 2. Clinical trial outsourcing market overview
Bahagi 3. Market breakdown by phase
– Phase I
– Phase III
– Phase III
– Phase IV
Bahagi 4. Market breakdown by application
– Cardiovascular diseases (CVDs)
– Gastrointestinal diseases
– Infectious diseases
– Musculoskeletal disorders (MSD)
– Neurological disorders
– Oncology
– Ang iba naman
Bahagi 5. Market breakdown by organization size
– Large enterprises
– Small and medium-sized enterprises (SMEs)
Bahagi 6. Market breakdown by region
– Hilagang Amerika
– Asya Pasipiko
– Europa
– Pahinga ng Mundo (ROW)
Bahagi 7. Mga pangunahing kumpanya
– Charles River Laboratories International, Inc.
– ICON plc
– IQVIA Holdings, Inc.
– Labcorp Drug Development Inc.
– Medelis, Inc.
– Parexel International Corporation
– Syneos Health, Inc.
– Thermo Fisher Scientific Inc.
– WuXi AppTec Co., Ltd.
Tungkol sa StrategyHelix
Pagtanggi